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Renal allograft rupture. J. J. Plaza, A. Barat, C. A/ferez, and J. R.
Gutierrez. Servicios de Nefrologia, Anatomia Patologica y Urologia,
FundaciOn Jiménez DIaz, Servicios Nefro!ogIa Hospital del Aire,
Madrid, Spain. From January 1970 to November 1982, ten patients with
acute allograft rupture occurred in 218 transplants performed at the
FundaciOn Jiménez DIaz (five cadaver, five living related donors) on an
incidence of 4.5%. The rupture developed between days 3 and 19 after
transplantation (mean, 8.4 days) during a period when the patients
required dialysis because of poor renal allograft function or were under
heparin treatment due to rejection. All patients had surgical explora-
tion: In four patients grafts needed to be removed. The other six graft
ruptures were repaired, and two of them functioned well (serum
creatinine 2 mg% and 1.3 mg%, respectively) 2 and 10 years later. The
other four failed to sustain function and the patients were returned to
dialysis 1 to 8 months later. The clinical course suggested that rejection
was the cause of rupture, but under light and immunofluorescence
microscopy, mild interstitial acute rejection was seen in four patients,
moderate interstitial in two patients, and only tubular damage without
any appreciable cellular acute infiltration or vascular damage in the
other two patients. Vascular rejection was present in two patients.
Edema in the interstitium was preponderant in six patients. The lack of
correlation between clinical and morphological manifestations of graft
rupture suggest that instead of the usual mechanisms of rejection, other
factors increasing vasopermeability (PAF, histamine, and so forth) are
mainly involved in the pathogenesis.
Deranged response of plasma dopamine-beta-hydroxilase (dI3H) to
postural changes and sodium depletion in essential and borderline parter-
ial hypertension and in normotensive relatives of hypertensive patients. J.
L. Aranda, L. Ruilope, J. M. Alcazar, R. Garcia Rob/es, C. Gomez
Roldan, A. Barrientos, J. Sancho, J. Rodicio, and A. Garcia. 1st
October and Ramon y Cola! Hospitals, and Department of Pharmacol-
ogy, Universidad Autonoma, Madrid, Spain. The participation of the
sympathetic nervous system in the development and maintenance of
arterial hypertension is controversial. After 3 mm of recumbency the
response of heart rate (HR), blood pressure (BP), DI3H, PRA, and
plasma aldosterone (PA) to 30 mm of deambulation followed by 60 mm
recumbency (blood samples obtained at time 0, 10, 30, and 60 mm) have
been measured in 15 normotensive volunteers, 9 essential and 12
borderline hypertensive patients, and in 5 normotensive relatives of
hypertensive patients before and after the administration of furosemide
(F, 80 mg orally). In volunteers, deambutation induced increments of
HR, diastolic BP, D/3H, PRA, and PA (P < 0.05 to 0.001). A positive
correlation was found between D/3H and both diastolic BP (r = 0.48, P
< 0.01) and PRA (r = 0.32, P < 0.05). Sodium depletion induced
increases of DI3H, PRA, and PA (P <0.02 to 0.01) in essential and
borderline hypertensive patients as well as in relatives of hypertensive
patients. D/3H levels were higher than in volunteers (P < 0.01) before F
administration and did not modify with deambulation nor with sodium
depletion. The higher levels of D/3H seemed to correspond to essential
hypertensive patients with hyporesponsive PRA. No correlation was
found between DI3H and any of the parameters measured in hyperten-
sive patients and their relatives. These results point to the existence of a
deranged behavior of DH before and during the establishment of
essential hypertension.
Clinical course and prognosis in a group of 52 patients with malignant
hypertension. R. MarIn Iranzo, F. Perez Lorente, J. R. Garcia Ortiz, L.
Quinones, F. Ortega, and J. Alvarez Grande. C. S. Ntra, Sra. de
Covadonga, Servicio de Nefrologla, Oviedo, Spain. Between 1973 and
1981, we saw 1611 patients with primary hypertension. Fifty-two
(3.23%) of them met the criteria of malignant hypertension. Forty-one
were male (79%) and 11 females with an age range between 36 and 81
years ( 51.7). The mean initial lying blood pressure (BP) was 220.09
26.6/128 16.3. Forty patients showed a grade III (G III) retinopathy
and 12 grade IV (G IV). Renal function was decreased in 79% of
patients (35% of them with serum creatinine (S-> 3 mg/dl) and cardiac
impairment was seen in 27% (80% of them as congestive heart failure).
Eighty-six percent of the patients had electrocardiographic (ECG)
evidence of left ventricular hypertrophy (LVH) moreover 64% with a
systolic overload (SO). Prevalence of neurologic impairment was 44%
(two-thirds of the patients as cerebrovascular accident and one-third as
hypertensive encephalopathy). Admission tests were: S. 3.06 2.41
mg/dl, hematocrit 39.46 8.6, potassium 3.95 0.83 mEq/liter, glucose
109 26 mg/dl, cholesterol 225 52.04 mg/dl, triglycerides 178 74.8
mg/dl, and uric acid 8.69 3.3 mg/dl. Proteinuria was present in 63% of
the patients and microhematuria in 26%. Of the initial patients (52),
eight died during the first 3 months after discharge, and six were lost
during the follow-up study. The remaining 38 patients were observed
between 6 and 84 months ( 29.05). With antihypertensive treatment
survival rates after 1, 2, 3, and 7 years were: 90, 84, 58, and 35%,
respectively. Thirty-eight percent (20) of our patients died within the
total follow-up (42% in G III and 25% in G IV P = NS). Mean BP and
prevalence of ECG changes were lower in patients of G III than in those
of G IV (P 0.05), but mean Scr was highest in Gill (P = NS). Causes of
death were chronic renal failure in 65% of the patients and vascular
accidents (specially neurotogic) in the remaining patients. In conclu-
sion: (1) Within 3 years with appropriate therapy, survival was above
50%. (2) Survival of patients in G IV was greater than in those in G III.
(3) A striking relationship was found between mortality and admission
5cr above 3 mg/dl. (4) Within 2 years of evolution, only 5% of living
patients showed a severe retinopathy (G III or G IV) while 70% showed
an ECG of LVH (40% with SO). Mean 5c. was unmodified.
Incidence and etiology of the liver dysfunction in renal transplantation.
J. L. Teruel, R. Marcen, M. L. Ce/ma, R. Bueno, L. Jimenez del Cerro,
R. Matesanz, C. Quereda, and J. Ortuño. Centro Ramon and Cola!,
Madrid, Spain. After infections liver dysfunction is the most common
cause of morbidity in the patient with a kidney transplant. Of the 60
patients who received a transplant, 28 developed 30 episodes of liver
dysfunction. All patients received blood transfusions during the proce-
dure. When persistent increases of two hepatic enzymes were ob-
served, serological studies were performed: HBsAg, anti-HBc, anti-S,
HA virus, EB virus, CMV, HSV, and HZV. The episodes were
classified in the following groups: (1) Pre-existing chronic hepatitis: six
patients (three HB virus, three non-A non-B virus). All patients
improved after transplantation, but four had a transient reactivation in
the immediate post-transplantation period. (2) CMV hepatitis: five
patients, early after the transplant (2 to 3 months). In all patients it was
an acute hepatitis with good evolution inside the clinical picture of
CMV infection. (3) Hepatitis of undeterminated etiology (probably non-
A non-B): ten patients, onset in the first 3 months after the transplant
and asymptomatic course. In eight patients the duration was short (<3
months); the evolution was excellent although the azathioprine was
maintained; two patients developed chronic hepatitis despite discontin-
uation of azathioprine. (4) Toxic hepatitis (isoniazid): two patients,
transient liver dysfunction without stopping the drug. (5) Intrahepatic
cholestasis: seven patients azathioprine-related, one patient with early
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onset and severe evolution, six patients with later onset (ito 8 months)
and better evolution (four with spontaneous remission and two when
azathioprine was reduced). The iiver dysfunction is a common compli-
cation in renai transplant recipients. The abnormalities were transient
and benign in most patients. Etiological diagnosis and prevention of
hepatitis B are now easy and very useful in the patient management.
Androgen therapy in nonferropenic patients on hemodialysis. J. L.
Teruel, C. Quereda, E. Martin, L. Orofino, F. Liano, and J. Ortuño.
Centro Ramon and Cajal, Madrid, Spain. Androgens are the only
therapeutic approach for treatment of noncarential anemia on hemodial-
ysis patients. Thirty-seven patients (25 male and 12 female) on hemodi-
alysis treatment for more than 9 months, with normal-high ferritin
levels, were selected. This group of patients has received a total of 43
cycles of nandrolone decanoate I M (200mg weekly, males, and 100 mg,
the females) during 6 months and after that a decreased dose until total
suppression. When hemoglobin (Hb) increment was higher than 1 g/dl
the patient was considered as a "responder." Twenty-four patients
responded to the treatment (65%) with a higher response from males
(69%) than from females (50%). In the group of responders, the Hb
increased from a basal level of 6.6 1.3 g/dl to a maximum of9.3 1.9
after the fifth month of treatment, without objective differences with
sex. The Hb decreased when the dose was reduced to its half (8.5 2.2)
reaching the basal values after the 3 months and finishing the cycle (6.8
1.5). Forty-one percent of responder patients become ferropenic
during the treatment, needing iron supplements. We have not found
significant differences between the responder group and the nonre-
sponder ones with reference to etiology, age, dialysis time, basal Hb,
basal ferritin, or previous blood transfusions. We found changes in the
voice and acne in two females and minimal transitory cholestasis in two
males. In conclusion, (1) the treatment with androgens is effective in a
high percentage of nonferropenic selected patients, (2) a higher index of
response in males, (3) the response is dose dependent, (4) low index of
side effects.
Development of donor-specific B lymphocyte antibodies in a controlled
trial of Cyclosporine A (CyA) after renal transplantation (ART). P.
Errasti, A. Ting, and P. J. Morris. University Clinic, Pamplona, Spain,
and Nuffield Department of Surgery, John Radcliffe Hospital, Oxford,
United Kingdom. Since January 1980, 73 consecutive cadaver donor
renal transplants have been performed, of which 33 were eligible and
entered into the trial. Twenty (20) patients were allocated to CyA and 13
patients to standard azathioprine and low dose prednisolone (AP)
therapy. Forty (40) patients were excluded for oliguria 6 hr ART or DR
compatibility. Patients on CyA were converted to AP at 3 months ART.
Serum samples collected weekly for the first 2 months from 18 patients
on CyA and 11 patients on AP treatment were screened for cytotoxic
antibodies against the B-lymphocytes obtained from cryopreserved
splenocytes of the specific-donor. The method used was the National
Institutes of Health technique, and killing of 10% above background
was considered positive. Both groups were comparable with respect to
the age, as well as HLA-AB and DR incompatibilities. In relation to
transfusion status ten out of 18 patients on CyA and two out of II in the
AP group had never been transfused. Ten patients in the CyA arm of the
trial were converted to AP at 3 months ART as planned and the
remaining eight patients have been converted between 2 to 8 weeks, for
unacceptable side effects, or more than two courses of rejection
treatment (according to protocol).
Transplant outcome No Positive (%) Negative (%)
CyA Failed
Successful
6
12
6 (100)
5 (42)
0
7 (58)
AP Failed
Successful
5
6
5 (100)
3 (50)
0
3
In conclusion, CyA is a potent immunosuppressive agent, as effective
as AP in the short-term effect (graft survival 73% versus 58%). It
abrogates the development of antibodies against donor antigens in
seven (39%) out of 18 patients in CyA (46% of 16 patients with negative
crossmatch and 54% of first cadaver donor renal transplants). It is not
effective in preventing rejection episodes, and their number was similar
in both groups. No correlation was seen (small number of patients)
between the appearance of donor-specific B-lymphocyte antibodies
ART and graft survival.
Acute acidosis syndrome caused by acid pH of deionized water:
Another complication of hemodialysis (HD). V. Perez Diaz, F. de Alvaro,
D. Sansegundo, J. M. Briso-Montiano, J. Bustamante, and N. S.
Jabary. Servicio de NefrologIa, Hospital Clinico Universitario, Valla-
dolid, Spain. A new complication of hemodialysis has recently ap-
peared in our unit. In some sessions of HD a few seconds after the
connection of the venous line, part of the patients suffered a generalized
sensation of heat, periboral paresthesias, extreme anxiety with feeling
of imminent death, intense agitation, tachychardia, and dyspnea, with-
out alterations in blood pressure and temperature. This clinical syn-
drome lasted 5 to 10 mm and was accompanied by an unusual frequency
of coagulation of dialyzers. The only abnormality found after a careful
study of all HD components was a low pH (4.85) of the deionized water
(DW), capable of bringing the pH of the dialysate down to 6.14 to 6.18
and the pH of the patients blood down to 6.46 to 7.17 during the first
minutes of the HD. A systematic measurement of DW pH and its
titration with NaOH when necessary eliminated the above described
complication. Our depurating system is a Culligan DA-50-S composed
of two ion exchange columns and worked correctly, that is, the
electrical resistivity of the DW, unique parameter of the quality of DW
automatically measured by this type of deionizer, was better than 0.18
MGoH x cm, but after a few hours of functioning the pH of the DW
dropped suddenly from 9 to 4. Additional analysis was done by the
manufacturer such as direct measurements of salinity and of detergents
and CO2 contents in the DW; all these parameters were normal. Finally,
neither the substitution of our equipment for new equipment nor the
addition of a mixed bed of resins on line with it, solved the problem.
Nowadays the regeneration of the columns is manually triggered
attending to the pH of the DW periodically measured. In conclusion, (1)
by unknown reasons some deionizers produce acidic water while the
quality of deionization is adequate. (2) An acid pH of the DW used in
HD produces a spectacular syndrome and increases the risk of coagula-
tion of dialyzers. (3) It is imperative to provide a pH control system in
the deionizers used in HD units.
Indium-ill labelled autologous lympohocytes in the diagnosis of kidney
graft rejection. J. M. Griño, A. Caraips, J. Martin Comin, M. Roca, A.
M. Castelao, R. Nogues, A. Andres, and J. Alsina. Servicio Nefrolo-
gIa, C. S. Principes de España, Barcelona, Spain. The use of labelled
lymphocytes as a diagnostic tool for kidney graft rejection was evaluat-
ed through imaging of the graft area after labelled cell trapping. After an
intravenous injection of the lymphocytes, sequential scans were taken
starting at 90 mm following injection until day 7. An activity index was
obtained by calculating the graft/contralateral iliac fossa (i); graft/iliac
crest (a); graft/spine (b) and spleen/graft (c) quotients. The diagnosis of
rejection was based on clinical, biochemical, isotopic and, at times,
histological data. A total of nine patients were studied. The control
group contained nine patients with kidney grafts and normal renal
function without signs of rejection or evidence of tracer trapping in the
graft area. The study group contained nine patients with acute rejection
and evidence of cell trapping in the graft area. The mean activity
indexes calculated 24 hr after intravenous injection were: Control
group: i = 1.02 0.05;a = 0.97 0.l4;b = 0.66 0.08;c = 14 3.9.
For the study group: i = 1.75 0.34; a = 1.25 0.3; b = 0.95 0.26; c
= 8 5.3. In summary, graft uptake of 11In-oxine labelled lympho-
cytes is a sign of rejection. Of the indexes calculated, i and c were the
more useful ones.
Influence of aluminum on calcium and parathyroid hormone metabo-
lism in hemodialysis and CAPD patients. J. B. Cannata, J. D. Briggs. B.
J. R. Junor, G. Beastall, and J. Herrera. Servicio de NefrologIa,
Hospital General de Asturias, Oviedo, Spain, and Renal Unit, Western
Infirmary, Glasgow, Scotland. Knowledge of parathyroid hormone
(PTH) and aluminum (Al) metabolism has increased in recent years but
their interrelationship remains unclear. In an attempt to shed some light
on its relationship we carried out this study in hemodialysis and CAPD
patients. We measured the serum Al, calcium (Ca), phosphorous (P),
and PTH at a single point in time in 86 patients who had been receiving
hemodialysis for longer than 6 months (6 to 110 months). The patients
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were separated into three groups according to their serum PTH levels
(normal < 600 ng/liter, borderline 600 to 900 ng/liter, high > 900 ng/
liter). Group 1 (29 patients, mean PTH 324 ng/liter) had significant
higher serum Al (P < 0.003) and serum Ca (P < 0.0125) levels than
Group 3 (47 patients, mean PTH 2765 ng/liter). These differences could
not be explained by the effect of drugs which are known to influence Ca,
Al, or PTH metabolism like vitamin D beta blockers or cimetidine
because both groups received similar amounts of these drugs. We
measured serially the serum Al, Ca, P, and PTH in 19 patients receiving
CAPD who were accidentally exposed to a high Al level in the dialysate
for 1 month. After using the high Al dialysate the mean serum Al rose
significantly (P < 0.0005). Over the same period the mean serum Ca
also rose significantly (P < 0.002) despite not changing Ca or vitamin D
therapy either during the period of study or the preceeding 3 months.
The mean serum PTH fell but the difference was not significant.
Fourteen out of the 19 patients had a more marked Al increase; in this
group, the serum Ca increase was considerably greater, and the fall in
PTH was significant. After a further 2 months using Al-free dialysate,
the mean serum Al and Ca levels fell to pre-exposure values. Our
findings that the serum Ca was higher in the group of hemodialysis
patients with higher serum Al and lower PTH levels and the occurrence
in CAPD patients of a rise in serum Ca during a period of Al toxicity add
strong support to the hypothesis that Al suppresses PTH through an
elevation of the serum Ca. However, a direct inhibitory action of Al on
the parathyroid glands cannot be excluded.
Effects of continuous peritoneal dialysis (CAPD) on calcium-phospho-
rus metabolism and parathyroid hormone (PTH). J. Luno, C. Gonzalez,
E. Junco, S. G. de Vinuesa, R. Jofre, S. Alonso, V. Barrio, and F.
Valderrabano. Hospital Provincial, Madrid, Spain. To investigate
mineral balances and the effect of CAPD on PTH, we performed 18
studies over 24-hr periods in five chronic uremic patients undergoing
CAPD for a mean duration of 5 months, who exchanged three 1.36%
and one 3.85% dextrose dialysate solutions (dwell times were 4 to 5 hr
and 8 to 10 hr, respectively). Ca concentration of dialysis fluid was 7
mgldl. Plasma and dialysate samples were collected during the 24 hr
period for: total Ca, ionized Ca, P, PTH (RIA, carboxyl terminal), and
calcitonine (RIA). Timed clearances and mass transfer studies were
performed. In addition, plasma variations of ionized Ca, P, PTH, and
calcitonine were analyzed. Daily Ca transfer oscilated between a
positive balance of 93 mg and a negative one of —6.6mg and correlated
inversely with the amount of fluid removed (r =
—0.94). The relation-
ship between net Ca gain and plasma Ca levels was not significant. The
daily removal of P was 339 35 mg and correlated with the serum P
levels. There were no significant plasma changes of ionized Ca, P, and
PTH along each exchange period. The mean clearance of PTH was 2.1
0.8 mI/mm, and the clearance of calcitonine was similar, implying
equivalent peritoneal clearances for peptidic hormones in the same
range of molecular weight. The equilibration gradient dialysate/plasma
concentrations for P was readily obtained after a dwell time of 10 hr.
However, D/P ratio for PTH after overnight 10 hr was only 0.3. The
equilibrium for ionized Ca occurred in less than 4 hr. In conclusion,
CAPD produces a minimal positive transfer of calcium which raises the
possibility of a defective bone mineral metabolism in CAPD patients
who require excessive fluid removal. Substantial amounts of PTH are
removed in CAPD; the implications of this PTH loss in the evolution of
hyperparathyroidism needs further long-term evaluation.
Small solutes kinetics in continuous ambulatory peritoneal dialysis
(CAPD). C. Gonzalez, J. Luflo, E. Junco, S. G. de Vinuesa, M. Resano,
R. Jofre M. Sanchez, and F. Valderrábano. Hospital Provincial,
Madrid, Spain. We studied peritoneal transport of small molecules in
relations to dwell peritoneal time in CAPD, 4 to 10 hr (dextrose
dialysate concentration 1.36 to 3.86 gIdl, respectively), using 2 liters
Dianeal fluid which contained 1.75 mmoles/liter Ca, 132 mmoles/liter
Na, 102 mmoles/liter Cl, 36 mmoleslliter lactate, and 0.75 mmoles/liter
Mg. Twenty studies were carried out in five chronic uremic patients
who had been established on CAPD at least 3 months at the time of the
study and the following biochemical parameters were measured in
simultaneously obtained blood and dialysate effluent: Na, K, Cl,
bicarbonate, urea, creatinine (Cr), ionized calcium (iCa), Ca, P, uric
acid, and glucose. Dialysate/plasma equilibrium (D/P = I 0.05) were
obtained at 4 hr for urea (0.95), Cl (0.98), and iCa (1). However, D/P
was 0.96 at about 10 hr for Cr, at the same time the equilibrium for Na
(0.95), K (0.95) and bicarbonate (1.04) was obtained. For P and Ca its
protein binding capacity obviate the equilibrium even after a 10-hr dwell
(P, 0.8; Ca, 0.64). The uric acid DIP ratio was 0.85 at 10 hr. Net glucose
uptake from dialysate averaged 91 9glday and correlated significantly
with dialysate concentration (y = 0.79 0.05 x r =0.97) and with dwell
time. We could obtain an excellent correlation between plasma and
peritoneal residual fluid concentrations after 8 to 10 hr overnight dwell
for urea (r = 0.99), K (c 0.97), Cl (r = 0.96), P (r = 0.92), and uric acid(r = 0.9). The correlations for the other parameters oscilated between
Cr (r = 0.82) and Na (r = 0.7). These results show that most of the
biochemical parameters of CAPD patients can be adequately and
simply predicted from dialysate data obtained after a 10-hr overnight
dwell. This may be helpful to reduce blood losses in laboratory
investigation to monitor biochemical data in clinical follow-up of CAPD
patients.
Influence of dialysis fluid on membrane biocompatibility. S. G. de
Vinuesa, J. Luño, C. Gonzalez, E. Junéo, M. Resano, V. Barrio, and F.
Valderrábano. Hospital Provincial, Madrid, Spain. Our previous find-
ing showing that isolated ultrafiltration prevents dialysis-induced com-
plement activation and hypoxemia but not the early leukopenia pro-
duced by blood-membrane interaction prompted us to study the influ-
ence of dialysis fluid on membrane biocompatibility. Six chronic uremic
patients treated by periodic hemodialysis underwent sequential ultrafil-
teration-dialysis studies, which consisted of 1 hr of ultrafiltration (UF)
followed immediately by 3 hr of hemodialysis (HD) with an acetate
fluid, using two different dialysis membranes: polyacrylonitrile (PAN)
and cuprophan. Blood samples were drawn from the arterial line at 0,
15, 30, and 60 mm of UF and at 15, 30, and 60 mm after the connection
of dialysis fluid and processed for leukocyte count (Coulter-S), oxygen
arterial pressure (P02, Technicon blood gases analyzer) and comple-
ment titers: C3, C4, factor B, whole complement (WC), and alternative
pathway (AP) by immunohemolysis or immunodiffusion. During the
first 15 mm of UF, the cuprophan membrane caused a marked leukope-
nia (5.400 362 to 2.400 340 cells/mm3) which was mild with the
PAN membrane (4.933 321 to 4.343 350 cells/mm3). This leukope-
nia was resolved within an hour of UF and there was no other
significant change of the leukocyte count during the next hour of HD.
P02 values which increased slightly during UF fell significantly during
HD with both membranes. However, the changes of the WC and C3
were not significant during the first hour of UF with PAN membrane,
but the connection of the dialysis fluid produces a marked decrease of
WC and C3 at 15 mm after initiating HD. Although there was a
significant decrease of AP with UF, this fall was more marked when the
dialysate was connected. Using the cuprophan membrane only was
seen as a significant decrease of WC at 15 mm of HD. These data clearly
demonstrate that leukopenia and hypoxemia are unrelated effects of
hemodialysis. Leukopenia depends on the membrane used, and hypox-
emia may be related to the use of an acetate dialysate. In addition, the
presence of dialysis fluid was necessary for membrane-induced comple-
ment activation suggesting an important influence of the dialysate bath
on membrane biocompatibility.
Nitroprusside (N)-induced modification of peritoneal mass transfer
coefficients (MTC). R. Selgas, A. Rodriguez-Carmona, M. E. Martinez,
J. Conesa, M. Salinas, F. Orti, M. Perez-Fontan, and L. D. Sanchez
Sicilia. C.S.S.S., La Paz, Authonomous University, Madrid, Spain.
Pharmacological manipulation is one of several methods by which
peritoneal physiology and pathophysiology are studied. MTC derived
from mathematical models, applied under special conditions, allows the
study of peritoneal diffusion in nonphysiologic situations. Vasodilators
act in part by augmenting the area available to peritoneal perfusion,
thus their effect is in part a measure of vascular reserve. Fifteen patients
treated with CAPD during periods of ito 26 months were studied. MTC
was determined for urea, creatinine, inulin, and PTH in basal conditions
and under the effect of 4.5 mg/liter of N i.p. Each study lasted 270 mm
without interference of other vasoactive drugs. The following modifica-
tions of MTC were observed (basal to under effect of N): urea 16.7
3.7 to 24.3 6 ml/min (P0.001); creatinine 7.1 3.4 to 12.4 5.37 (P
0.001); PTH from 0.44 0.33 to 1.3 0.45 (P 0.001); inuline 2.3 1.3
to 2.3 I (NS). Possible augmented MTC in correlation with greater
molecular weight under vasodilator effect was evaluated by comparing
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the following MTC ratios (basal to under effect of N): creatinine/urea
0.41 0.12 to 0.5 0.1 (P 0.01); PTH/urea 0.03 0.017 to 0.054
0.019 (P 0.005); PTH/creatinine 0.074 0.036 to 0.112 0.038 (P 0.01).
The induced increment in MTC was calculated in each patient and
compared to the mean value obtained to correlate the following
variables: peritonitis (r =
—0.26, NS), body surface (r = +0.29, NS);
time in CAPD (r =
—0.32, NS), time in ESRD(r = —0.31, NS), age(r =
—0.1, NS); no correlation with mean blood pressure was made. Our
data indicate the conservation of vascular reserve (or peritoneal perme-
ability reserve) during CAPD. This reserve has individual qualities. The
incremental increase of transfer across the peritoneal membrane in-
duced by Nitroprusside is not only dependent on molecular weight.
Ocular changes in idiopathic nephrotic syndrome after corticosteroid
therapy. J. M. López-Gómez, P. Ba/ado, F. Gómez Campderá, C.
Cones, A. Luque, and A. Lecea. Services of Pediatric Nephroiogy and
Ophthalmology, Hospital Provincial, Madrid, Spain. Ophthalmologic
changes after prednisone treatment were studied in 45 patients (age, 3.1
to 14.2 years). The total dose ranged between 30 and 947 mg/kg.
Histological examination was obtained in 23 patients (nine minimal
change nephropathy, one focal global sclerosis, 11 diffuse mesangial
proliferation, and two focal glomerulosclerosis). Seventeen patients
were treated with other immunosuppressant agents (chlorambucil or
mechloretamine). Subcapsular lens opacities were classified using four
grades of intensity (modified Crews's classification). Fifteen patients
had no changes or minimal (grade 1), 23 were assigned to grade 2, two to
grade 3; no child had grade 4 opacities. Prednisone total dose had a
significant correlation to lens opacity grade (P < 0.01), and it was not
related to the renal histology or other immunosuppressant agents
administration. All the patients were divided in three groups according
to age. The severity of the posterior subcapsular cataract was increased
in the oldest group that also received the higher total dose (P < 0.025).
We were unable to determine the minimal dose of prednisone which
produced cataracts because of the scattered dispersion of the date.
Nevertheless, there were some patients that developed posterior sub-
capsular cataracts with a small dose. Corrected visual acuity was
normal in all but one child. Vitreous disturbances of the macrofibrillar
degeneration type were found in 64.7%. Retinal changes, characterized
by the presence of variable ischemic areas, were found in 64.2%.
Neither vitreous nor retinal alterations showed a significant correlation
with corticosteroid dose. All the patients had a typical phenotype
characterized by epicanthic folds and hypertelorism of variable degree.
We conclude, that there is a high incidence of posterior subcapsular
cataract in nephrotic patients treated with steroids. The severity
correlates well with total dose, with some individual susceptibility.
Vitreous and/or retinal alterations are found in two thirds of the patients
without relation with steroid dose. A typical ophthalmologic phenotype
is characteristic in these patients. Regular and careful ophthalmologic
examinations are necessary to control the progression of ocular compli-
cations in nephrotic patients receiving steroid therapy, though the risk
of permanent visual loss is low.
Immediate effect of peritoneo-venous Le Veen's shunt in sodium
tubular handling of cirrhotic patients. P. Gomez-Uliate, J. Del Hoyo, A.
Vallo, J. L. De Sancho, L. De L.a Torre, J. Montenegro, J. Moran, R.
Muniz, J. Ocharan, F. V/liar, J. Aranzabal, R. Saracho, and I.
Lampreabe. Servicio de Nefrologia, C.S.S.S. 'Enrique Sotomayor,"
Biibao, Spain. The sodium tubular handling was studied in the first 7
days following peritoneo-venous Le Veen's shunt insertion in eight
patients (seven men and one woman), with ages between 38 and 63
years, affected by hepatic cirrhosis in seven patients and peritoneal
carcinomatosis in one; both situations with severe ascitis were unre-
sponsive to diuretic treatment. We determinated GFR, PNa, Pk, BUN,
PCR, UNa, Uk, CNa, EXFNa, Ck%, 24 hr diuresis, body weight, and
abdominal perimeter 3 days before and daily during 1 week before the
shunt's insertion. A significant increase of GFR from 43.7 31.1 ml/
mm to 81.4 31.9 mI/mm (P < 0.01) had been found with a significant
decrease in PCr from 1.32 0.48 mg% to 0.75 0.25 mg% (P < 0.002),
and BUN from 29.1 16 to 12.1 8.9 mg% (P 0.005). The diuresis
increased from 796 355 to 2300 945 mI/day (P < 0.0005). The
EXFNa increased from 0.48 0.30% to 2.09 1.34% (P < 0.001)
without significant changes in Ck%, V%, or PNa and Pk. We correlated
individual basal results with those obtained the next 7 days to shunt's
insertion and found significant changes in the majority of patient body
weight, abdominal perimeter, UNa, and CNa. The Le Veen's shunt
insertion in cirrhotic patients produced: (1) A significant increase in
diuresis, UNa and EXFNa. (2) A significant improvement in GFR from
patients with previous renal failure. (3) A significant decrease on body
weight and abdominal perimeter. (4) We didn't appreciate significant
changes in potassium tubular handling because of the persistence of
hyperaldosteronism. All of these parameters are very useful to valve
the shunt's functionalism.
Uremic hyperprolactinemia: Size heterogeneity of circulating hPRL
and its relationship with renal function. D. del Pino, M. V. Cachofeiro,
D. RodrIguez-Puyoi, J. M. López-Novoa, J. E. Martin-Oar, and S.
Casado. Renal Physiology Laboratory, Department of Nephrology,
Fundación Jiménez DIaz, Madrid, Spain. Serum hPRL and its size
heterogeneity were studied in 11 male patients with chronic renal failure
on maintenance hemodialysis (HD), in five male patients with chronic
renal failure (CRF) (Ce. range, 5 to 30 mI/mm) and in five normal men
(C). Venous blood samples were obtained in basal conditions (B) and
after 500 zg TRH i.v. (20 and 120 mm). Sera were chromatographed by
gel filtration in Sephadex G-l00. Human PRL was measured by RIA.
Main results (ng/mI; SEM) were:
Total Little Big Big-Big
B 12.5 2.3 8.0 1.6 2.3 0.7 2.2 0.2
C 20 51.3 7.3' 41.9 55a 7.8 1.2' 1.6 0.8
120 14.3 39b 10.7 2.4k 2.3 0.9k 1.3 0.5'
B 16.0 1.1 13.8 1.2' 1.3 0.6 0.8 0.5c
IRC 20 36.1 3.7' 32.4 3.7' 3.0 0.3' 0.7 0.4
120 24.6 4.6ab 23.1 39a. 1.1 0.6k 0.4 0.4
B 28.4 3.6d 27.1 33c.d 0.8 0.3' 0.5 0.3'
HDP 20 39.8 3.5' 37.6 3.5' 1.5 Ø3cd 0.7 0.3
120 38.2 35ac.d 36.2 35a.cd 1.4 0.3 0.7 0.4
P <0.05 vs. B; b P < 0.05 vs. 0.20;' P <0.05 vs. C; P <0.05 vs.
LRC
PRL disappearance rate (PDR = PRL20 — PRL120IPRL20) was used as
an index of hPRL clearance rate. In HD, PDR was not significantly
different from 0. In CRF patients there was a high correlation between
Ccr and PDR for both total hPRL (r = 0.93) and little hPRL (r = 0.93).
These results suggest that uremic hyperprolactinemia is mainly a
consequence of GFR reduction, which leads to little hPRL accumula-
tion. Data do not support a major role for the hypothalamic-hypophyse-
al dysfunction in uremic hyperprolactinemia.
Effect of captopril in sodium and water management in decompensated
cirrhotic patients. C. Caramelo, J. Gómez Berné, H. Sa/ata, J. M.
Castriilo, S. Casado, and J. M. López-Novoa. Nephrology, Internal
Medicine and Gastroenterology Services, Fundación Jiménez DIaz,
Madrid, Spain. A group of seven male patients aged 57 3 years (
SD) was studied with histologically proven hepatic cirrhosis in the
decompensated phase, without hemodynamic compromise or renal
insufficiency (Cc. 60 mI/mm). After medication withdrawal and a
basal period of 4 to 6 days, patients received captopril (Sq 14225), 12.5
mg t.i.d. (five individuals) and 25 mg t.i.d. (two individuals); four
patients were also studied after captopril withdrawal. During the entire
study, a diet of 30 mEq sodium and 900 ml water was given each day.
Daily water and sodium balance, aldosterone and renin plasmatic
levels, functional and clinical parameters were recorded. Captopril
induced significant increase in diuresis (835 285 to 1101 280 ml/24
hr), sodium urinary excretion (13.1 9.5 vs. 27.7 23), free water
clearance (—0.482 0.33 vs. —0.19 0.23 mI/mm), Na clearance (0.053
0.047 vs. 0.1102 0.1196), and a fall in urinary osmolality (515 120
vs. 398 159 mOsm/kg). Plasma renin activity increased from 5.5 4.5
to 13.4 20.6 ng/ml/hr, and aldosterone decreased from 43.4 42 to
18.1 9 ng/dl, but these variations were not significant. All these
changes were fully reversed by captopril withdrawal. No other clinical
or functional changes, or collateral effects were observed. It is conclud-
ed that low dose captopril increases Na and water excretion in
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decompensated cirrhotic patients. Nevertheless, its therapeutic appli-
cation is doubtful.
Heterogenicity of the renal cortical vasculature in response to the same
vasomotor agent. J. F. Macias Nuñez, M. J. Olsen, J. C. Romero, and
F. G. Knox. Hospital Universitario, Salamanca, Spain, and Mayo
Medical School, Rochester, Minnesota. The role of adenosine as a
metabolic regulator of GFR and renal blood flow (RBF) has been
attributed to its specific vasoconstriction in the kidney. Intrarenal
infusion of adenosine is characterized by an early vasconstriction
followed by a late recovery of RBF to values equal or above the
preinfusion levels. This study was undertaken to analyze the intracorti-
cal distribution of RBF during the early and late phase of the iritrarenal
infusion of adenosine. RBF distribution was measured with radiola-
belied microspheres in two groups of anesthetized sodium-depleted
dogs. In the first group of six dogs, the distribution of cortical RBF, so
far unknown, was determined. In a different group of six new dogs,
early and late phases of intrarenal infusion of adenosine were studied.
There were no significant changes in blood pressure.
Blood flow
mi/mm/mg C C2 C3 C4
Control 5.7 0.8b 6.2 1.1 4.7 1.1 2.9 0.7
Vasoconstriction 3.3 0.7 3.2 0.9 2.6 0.7 1.5 0.5
Vasodilation 5.3 0.9 6.2 0.9 5.7 0.8c 4.09 0.7a
a C1-C4 zones from superficial to deep cortex.
b SEM.
a P < 0.05.
A uniform reduction of RBF to all cortical zones was observed during
the vasoconstrictor period, whereas the vasolitator phase was defined
by a selective deep cortical vasodilation without changes in the superfi-
cial areas. From the above results, we conclude firstly that the cortical
renal vasculature does not respond uniformly to the intrarenal infusion
of adenosine, and secondly, that during the vasoconstrictor phase there
is a similar reduction of RBF to all the cortical vasculature.
Indications and hazards of transplantectomy. F. Sousa, M. Arias, J.
M. Pastor, J. Avedillo, S. Aguado, R. Escallada, A. L. M. de
Francisco, J. G. Cotorruelo, J. A. Zubimendi, and C. Liamazares.
Servicio de Nefrologia and Laboratorio de Histocompatibilidad,
C.M.N. "Marques de Vaidecilla," Santander, Spain. Kidney graft
removal was performed 31 times in 28 patients of a series of 113 kidney
transplants. Indications for nephrectomy were as follows: (I) fever with
no evident source of infection in an otherwise irreversibly rejected
kidney (19 patients); (2) renal artery thrombosis (4 patients); (3)
unreparable urinary fistulae (3 patients); (4) relapse of glomerulonephri-
tis anti-GBM (2 patients), cortical necrosis (1 patient) chronic rejection
with intractable systemic hypertension (1 patient), and pyonephritis (1
patient). Nephrectomy was done early (in the first 4 months after
transplantation) in 23 patients (74.2%) and between 6 and 48 months in
eight patients. The graft removal was followed by significative compli-
cations: seven focal infections; five patients developed postoperatory
hemorrhages and in three of them additional surgery was done; two
patients with eventrations and one patient with pneumonia. Two
patients died of hemorrhage and sepsis. Immunological studies revealed
a high titer of anti-HLA antibodies, occasionally against donor antigens
not present in the receptor. Graft removal does not generally need to be
done and its indication must be contemplated in each patient on the
basis of clinical criteria. Nephrectomy in these immunosuppressed
patients carries a high risk of mortality and complications. Qualified
surgery and prophylactic antibiotherapy are recommended.
Beta adrenergic modulation of extrarenal potassium disposal in termi-
nal uremia. A. Martinez- Vea, J. Montoliu, L. Andreu, A. Torras, J.
Lopez-Pedret, F. Rivera, and L. Revert. Hospital Clinic, Barcelona,
Spain. To study the effect of epinephrine (E) on potassium (K)
metabolism, an E infusion (0.1 ,ug/kg mm for 30 mm) was carried out
in 12 essentially anuric and usually hyperkalemic maintenance hemodi-
alysis (HD) patients, 72 hr after their last HD. Immediately following
the E infusion two groups emerged. In group I (five patients), serum K
decreased from a basal value of 6.6 0.2 (mean SE) to 5.4 0.1 EqI
liter (P < 0.005), and there were increases in heart rate (68 3 to 87 3
bpm, P < 0.005), serum glucose (76.4 2.8 to 128.4 3.2 mg/dl, P <
0.001) and insulin levels (16.4 1.8 to 22.8 1.8 mU/mi, P <0.05). In
group 2 (seven patients), serum K did not decrease (6 0.3 to 6 0.3
mEq/liter), heart rate and insulin levels remained unchanged (70 2 to
79 3 bpm, and 16.5 1.8 to 19.7 1.3 mU/mi, P = NS), but serum
glucose did increase (83.3 3.3 to 116.6 6.2 mg/dl, P < 0.001).
Plasma renin, aldosterone, and arterial pH did not change in either
group. Propranolol (1.4 pg/kg mm for 30 mm), when administered
simultaneously with E to four patients from group 1, totally blocked the
decrease in serum K (6.6 3 to 6.6 0.2 mEq/liter). Patients from
group 2 had higher preinfusion endogenous E levels than patients from
group 1(286.1 79.6 vs. 151.3 52.6 pg/mI, respectively). Thus, in HD
patients, beta adrenergic stimulation enhances extrarenal K disposal,
but 50% of patients may fail to lower K with E infusions, perhaps
because of receptor occupancy due to higher endogenous E levels.
"Non A — non B" hepatitis in hemodialysis patients: Diagnosis and
evolution. R. Matesanz, J. L. Teruel, J. Gonzalez Sainz, R. Bueno, R.
Marcén, C. Quereda, andJ. Ortuno. Centro Ramón and Cajal, Madrid,
Spain. Non A — non B hepatitis viruses are becoming the most
frequent kind of hepatitis in virus B-free hemodialysis (HD) units. The
diagnosis can only be made by exclusion of known etiological factors.
Since 1977 to 1981, 154 patients have been dialyzed in our Unit (70 at
home, after a training period). During this time 43 enzymatic elevations
were detected (one of seven, three patients per year). HBs Ag (RIA)
and serum alanin-transferases (SMAC-20) were determined monthly in
hospital patients and every 3 months at home. HBc Ab and HBs Ab
(RIA) were also tested yearly. Whenever an enzymatic elevation was
detected, after ruling out drug toxicity, cardiac failure and bacterial
infection, a wide virological screening was done (Epstein-Barr virus,
CMV, 1gM-HA, HBs Ag, HBc Ab, and HBs Ab). According to these
criteria, hepatitis viruses were classified as follows: virus A: I, virus B:
1 (in chronic carrier), CMV: 1, EBV: 2, nor-etandrolone: 4, and "non A-
non B": 34 (79%). The distribution of "non A — non B" hepatitis was
uniform along these 4 years without epidemic outbreaks. Bilirubin was
raised only in one patient (4 mg/dl). There were no differences between
hospital and home HD patients incidences (10.7 vs. 10.6/100 patients
per year). Blood transfusion antecedent existed in 16 patients (47%)
during the previous 3 months and reached 64% when the hypothetical
incubation period was extended to 8 months. Only 10 patients (29%)
had a limited course, while 16 (47%) had a chronic evolution (more than
6 months), and eight (23%) showed relapsing enzymatic elevation. Non
A — non B hepatitis viruses are the most frequent kind of hepatitis in
HD units whenever virus B prophylaxis is effective. Blood transfusions
seem to play an important role in the transmission. Evolution is by no
means banal, as more than 70% became chronic or showed a relapsing
pattern.
Specific disorder of magnesium renal tubular transport in diabetes
mellitus. Its physiological and clinical relevance. G. Defiu!ó, A. Rapado,
and J. L. Herrera Pombo. Fundación Jiménez DIaz, Madrid, Spain.
The incidence of hypomagnesemia in diabetes mellitus (DM) which has
been correlated with its vascular complications is well known. Eighty-
one DM patients (53 insulin-dependent and 28 noninsulin-dependent)
with normal renal function were compared with 80 normal individuals
(C) and matched by sex and age. The values (media SD) of
magnesemia, erythrocyte magnesium (EMg), and magnesium and calci-
um tubular handling, expressed by their rate of renal excretion (MgER
and CaER) were studied. These values were correlated with different
clinical and therapeutical situations. There were no differences in the
values of magnesemia (DM = 1.94 0.15, C = 1.98 0.15 mg/dl); EMg
(DM = 4.77 0.68, C = 4.90 0.38 mg/dl) nor in CaER (DM = 0.132
0.59, C = 0.124 0.068 mg/100 GFR). The MgER was high (P < 0.001)
in DM (0.102 0.060 vs. C = 0.055 0.020 mg/lOO GFR). In DM, we
found hypomagnesemia (<1.8 mg/dl) in 11 patients (13.5%), decrease of
EMg (<4.5 mgldl package red cells) in 24 patients (38.7%), and
hypermagnesuria in 56 patients (69.1%). No differences were found in
DM with regard to the existence and/or severity of retinopathy, good
therapeutical control or with the levels of glycemia or glycosuria. In
DM, the decrease of magnesemia is due to a defect in the magnesium
renal tubular transport. This disorder is specific since no concomitant
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disturbances in the transport of calcium have been associated. This
suggests the existence of different mechanisms in the tubular handling
of the divalent cations. This disorder is independent from the therapeu-
tical control, from the values of glycemia and glycosuria, and from the
grade of diabetic vasculopathy. Other compensatory mechanisms (hor-
monal? bone storage?) would explain the absence of clinical signifi-
cance or a persistant hypomagnesemia in the hypermagnesuria of DM.
Evolutive value of factor VIII plasmatic levels in severe essential
arterial hypertension (SEH). L. Orte, A. Pardo, R. Maresanz, J. L.
Navarro, and J. Ortuño. Centro "Ramon Y Cajal," Madrid, Spain.
Factor VIII, synthesized in vascular endothelium, has been shown to be
elevated in SEH and directly correlated with the visceral involvement
(VI). To study its role as evolutive marker of VI we measured serially
plasmatic levels of F VIII coagulant (F VIII coag = one-stage clotting
assay) and F VIII antigenic (F VIII rAg = Laurell immunoelectrodiffu-
sian) in 12 essential hypertensive patients with severe VI, tabulated
according to diastolic values and funduscopic, cerebral, cardiac, and
renal involvement, until blood pressure control, and VI recovery or
stabilization. F VIII levels are given as percentage of normal obtained
from a "pool" of 48 healthy controls. Basal levels of F VIII Coag and
rAg were elevated in all patients; a significant decrease of both factors
(P < 0.001) was observed in II of them, once attained clinical control
after a mean time of 1.8 months.
Basal ClinicaI control
F VIII Coag (%) 245.5 70 128 46
F VIII rAg (%) 180 76 106 64
F VIII levels remained above normal in four patients. The only
difference with those who normalized them was a more prolonged
known evolution of hypertension (5: 11.25 vs. 6.4 years). Only one
patient with unmodified values had advanced renal insufficiency, which
did not improve despite blood pressure control. F VIII Coag and F VIII
rAg are good markers of VI in basal evaluation of SEH. There is a
correlation between normalization of their levels and VI recovery once
blood pressure is controlled. Serial measurements of these factors may
allow a best follow-up of these patients.
Renal involvement in toxic oil syndrome. V. Gutierrez Millet, J.
Navas, G. Usera, C. Prieto, J. M. Alcazar, I. Bello, andJ. L. Rodicio.
Ciudad Sanitaria "1° de Octubre," Madrid, Spain. Four out of 842
(0.47%) patients admitted because of "toxic oil syndrome" (secondary
to ingestion of adulterated rapeseed oil) developed glomerulonephritis.
They were three males and one female ranging from 5 to 72 years of age
who were admitted on May 1981 with fever, interstitial pneumonitis,
hypoxia, skin rash, and eosinophilia, but without clinical nor analytical
evidence of renal disease. After a period of 27 to 66 days they showed
clinical symptoms of acute renal disease: acute nephritic syndrome (two
patients), nephrotic syndrome plus renal insufficiency (one patient), and
rapidly progressive glomerulonephritis treated with hemodialysis (one
patient). Bacteriologic and virologic studies were negative. C3 and C4
serum levels were elevated and all of them had positive antinuclear
antibodies; antiDNA antibodies were negative. The kidney biopsy
specimens revealed glomerular, vascular, tubular, and interstitial
changes. Two patients had diffuse proliferative endocapillary glomeru-
lonephritis, one had lupus-like membranoproliferative glomerulonephri-
tis, and the fourth patient showed a diffuse proliferative extracapillary
glomerulonephritis with 80% of crescents. The first three patients
exhibited IgG, 1gM, Clq, and C3 deposits; the fourth patient only had
fibrin deposition in the crescents. Electron microscopy revealed suben-
dothelial (three patients), subepithelial (two patients) and mesangial
(one patient) electron-dense deposits. The vascular lesion consisted of
endothelial degeneration and proliferation with partial luminal oblitera-
tion; there was fibromyxoid intimal proliferation, similar to that seen in
scleroderma. In addition, there was an inflammatory infiltrate made up
of lymphocytes in the subendothelial region of medium-sized arteries
and veins. Tubules displayed degenerative epithelial changes, and the
interstitium contained a moderate infiltration of lymphocytes and
eosinophils. Two patients were treated with steroids and cyclophospha-
mide and had marked clinical improvement. The review of 22 autopsies
demonstrated two patients of focal segmentary glomerulonephritis, and
14 patients with vascular lesions of the kidneys.
Effect of cyclophosphamide on peripheral T cell subsets in polyarteritis
nodosa. M. A. Figueredo, C. Garcia-A guado, M. Rodriguez-Mahou, J.
A. foyer, andR. Patiño. Sección de Immunologia, Hospital Provincial
y Departmento de Medicina Interna, Hospital ClInico, Universidad
Complutense, Madrid, Spain. In eight patients with polyarteritis no-
dosa (PAN) treated with cyclophosphamide (CY) (2 mglkg/day), we
investigated the effect of the drug on subpopulations of circulating T
lymphocytes, using specific mouse monoclonal antibodies (OKT re-
agents) that react with specific subpopulations of human lymphocytes.
OKT3 recognizes all human T cells, OKT4 reacts with T cells which
include the inducer subset, while OKT8 recognizes suppressor-cytotox-
ic populations. Results are expressed as the percentage of lymphocytes
reacting with OKT antibody. Analyses were made before treatment (six
patients), after 3 months of treatment with CY (six patients), at the end
of month 6 of treatment with CY (four patients), and when more than 6
months had elapsed since CY withdrawal (three patients).
Treatment Group No OKT3+% OKT4+% OKT8+% Quot4/8
Normal N 20 71 7 51 6 31 5 1.6 0.2
No treat. 1 6 68 6 56 3 24 3 2.3 0.3
CY 3 months 2 6 66 4 42 lla 35 10 1.3 0.6a
CY 6 months 3 4 59 5 36 15 32 14 1.25 0.8
CY stopped 4 3 59 12 35 10 31 6 1.1 0.35
>6 months
a P < 0.01 (Student's paired t test between groups 1 and 2.)
The results clearly show a decrease in the OKT4+ subpopulation with a
moderate increase in the OKT8+ subset, which results in a marked
reduction in the OKT4/OKT8 ratio. This effect is evident from month 3
of treatment and does not disappear with CY withdrawal. Only one
patient who died in month 7 of the disease, with active vasculitis, did
not show any change in her T cell subsets after 6 months of treatment
with CY. We conclude: (1) CY develops the "resetting" of a new
balance between peripheral T cell subpopulations, (2) this effect of CY
may help to explain its action as an immunosuppressive agent.
The hypothalamic origin of a natriuretic-pressor substance. J. Diez, P.
Errasti, J. Villaro, A. Monzón, and A. Purroy. Clinica Universitaria,
Pamplona, Spain. It has been suggested that in some genetic forms of
hypertension the exaggerated release of a hypothalamic natriuretic-
pressor substance (HNPS) might be responsible for high blood pressure
(BP). To analyze the existence of a HNPS, a relationship was investi-
gated between natriuresis, BP and the secretory activity (SA) of the
anterior hypothalamus (AH) in control Wistar rats, in rats whose
extracellular space was expanded with saline solution (ESS), in rats
expanded with dextrose solution (EDS) and in rats submitted to high
sodium perfusion of the cerebro-ventricular system (CVSP). The SA of
the hypothalamic cells was evaluated according to morphometric
techniques. As compared to control rats the ESS and CVSP rats
showed an increase in natriuresis, P < 0.001, and an increase, P <
0.005, in morphometric parameters of SA of the AH. BP was increased,
P < 0.001, in the ESS rats, but was not significantly increased in CVSP
rats. In the EDS rats natriuresis was decreased, P < 0.001, morphomet-
nc parameters showed a decrease, P < 0.005; in SA of the AH and BP
was increased, P < 0.005. It is concluded that in some experimental
conditions there exists a relationship between natriuresis and SA of the
AH, but no relationship can be found between BP and SA of the All.
Changes in cerebro-spinal fluid (CSF) sodium (Na) content of the rat.
Effects on the urinary excretion of Na and prostaglandins and on the
plasmatic capacity to influence vascular prostacyclin, PG12, synthesis. J.
DIez, F. Guarner, M. Goñi, R. Virto, and A. Purroy. Clinica Universi-
taria, Pamplona, Spain. The effect of experimental changes was
investigated in CSF Na content on the urinary excretion of Na and
prostaglandins and on the plasmatic capacity to influence vascular
synthesis of PG12 in rats submitted to perfusion of the cerebro-
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ventricular system with artificial CSF which contained different
amounts of NaCI. Twenty rats were divided into four groups of five
animals: Group 1: control rats; group 2: rats perfused with normal Na
CSF; groups 3 and 4: rats perfused with high and low Na CSF,
respectively. After 2 hr of perfusion; no significant changes were
observed in group 2 as compared to controls. Group 3 rats showed an
increase in natriuresis P < 0.02, a decrease in urinary excretion of
6keto-PGFI, P < 0.02, and a decrease in 6keto-PGF1 release, P < 0.05,
from dog aortic endothelium as compared to group 2 rats. Group 4
presents a lesser natriuresis, P < 0,02, and a lesser urinary TXB2, P <
0.05, than that of group 2. These results show that changes in CSF Na
can influence urinary excretion of Na and prostaglandins and this effect
may be related to changes in the plasmatic presence of a factor that
suppress generation of PGI2 by vascular tissue.
Nephrotic syndrome with 1gM mesangial deposits: Response to thera-
py. A. Gonzalo, F. Mampaso, N. Gallego, R. Marcén, J. Sabater, and
J. Ortuño. Centro Ramón y Cajal, Madrid, Spain. We have studied 19
patients with ages ranging from 3 to 45 years with idiopathic nephrotic
syndrome. Eight patients were male and II female. On light microsco-
py, mild to moderate increases in cells and mesangial matrix were
observed. By immunofluorescence, generalized and diffuse deposits of
1gM, with or without C3, in the glomeruli were demonstrated in all
patients. Electron microscopy showed electron dense deposits in the
mesangium in 16 patients. At the time of biopsy, serum 1gM was
significantly raised (P < 0.01). Two patients experienced spontaneous
remission and the remaining 17 were treated with prednisone. Twelve
patients were steroid-responsive and five were steroid-resistant. Only
one of the five steroid-resistant patients treated with chlorambucil
showed response. We compared the course of these patients with those
of II patients presenting idiopathic nephrotic syndrome without immu-
nofluorescent deposits, aged 3 to 59 years, who received the same
therapy. One patient experienced spontaneous remission, eight patients
were steroid-responsive, and two steroid-resistant. Mean follow-up was
3 years for the two groups. With regard to the response to therapy, no
distinction could be drawn between the two groups in the early
response to steroid treatment. In summary, the presence of 1gM
deposits in idiopathic nephrotic syndrome is not a marker for the early
response.
Membranoproliferative glomerulonephritis: Clinical and immunologi-
cal studies. A. Gonzalo, D. Mirete, F. Mampaso, N. Gal/ego, L. One,
R. Matesanz, and J. Ortuno. Centro RamOn y Cajal, Madrid, Spain.
Forty-two patients with membranoproliferative glomerulonephritis
(MPGN) were studied (16% of primary glomerulonephritis). Twenty-
two were male and 20 female, with ages ranging from 7 to 66 years.
Renal biopsy was performed within the first year of the disease.
Morphologically, 36 patients were classified as MPGN with subendoth-
dial deposits (SED) and six patients as dense deposits disease (DDD).
At the time of biopsy nephrotic syndrome was present in 57%, impaired
renal function in 29%, hypertension in 21%, hematuria in 83%, and
proteinuria in 32%. The actuarial survival was 56% at the fifth year.
Renal failure was never observed in non-nephrotic patients but devel-
oped in 77% of nephrotics. At the last examination, after an average
follow-up of 4 years (1 to 9 years), 15 patients were on regular
hemodialysis, five had chronic renal failure, ten showed normal renal
function, and 12 were protein-free. All patients with sclerotic lesions
and/or epithelial crescents presented a progressive course. The actuar-
ial survival of the patients with normal C3 (33%) was similar to those
with low C3 (66%). C3NeF was positive in 63% of the MPGN with SED
with low C3, and in all patients with DDD. In summary, (1) prognosis
was more severe in patients with nephrotic syndrome. Presence of
sclerotic lesions and/or epithelial crescents was always associated with
a poor prognosis. (2) C3NeF was absent in 37% of hypocomplemente-
mic MPGN with SED, suggesting another mechanism (immune com-
plex) or the presence in the serum of a inhibitor of this factor.
Primary hyperparathyroidism (HPH). Ca-P balance post-parathyroid-
ectomy (PP). P. Barceló, J. Lopez-Li/b, J. Ferré, J. M' Santaularia,
and G. del Rio. Fundación Puigvert, Barcelona, Spain. The Ca-P and
urinary pH increase can explain the formation of calculi in PHP.
Parathyroidectomy (PP) must include normalization of Ca-P and avoid
the recidive of lithiasis. Out of 34 PHP, 21 patients were controlled
between 22 and 124 months. The following controls were done after
surgery in each one of them: (1) lithiasis evolution (urography); (2) bone
lesions (radiology); (3) existence of ulcer (gastroduodenal); (4) Ca-P;
alkaline phosphatases; calciurial24 hr; phosphatunal24 hr; (5) PTH,
cyclic AMP/creatininuria/24 hr; hydroxiproline; (6) Ca-P balance in
controlled diet; (7) calculus composition (s). These data were studied;
before PP, at short term PP (2 to 4 months) and at long-term (20 to 24
months). The elimination of calculi ceased in 16; it continued in two and
improved in three. Two of them had an ulcer, one was asymptomatic
and the other persisted. Calcemia, phosphoremia, and PA became
normal in all: in one patient after 118 months calcemia was higher (10.5
to 10.8 mg%). In 12 patients the calciuria diminished; in six it increased
and in three it did not change (immediate PP). In the long-term PP, it
increased in eight; in 11 it was normal and in two it was not modified.
Phosphaturia diminished in 18; increased in two and did not change in
one (short- and long-term PP). VFH, AMP cyclic and hydroxiproline
became normal in 13 of 14 and 8 of 8. Six needed treatment with
cellulose phosphate and/or diuretics after PP. In conclusion, parathy-
roidectomy avoids lithiasis progression in 85% of patients; in short-term
as well as long-term PP Ca-P abnormalities and urinary pH persist in
48% of patients; and 26% need medical care.
Extrarenal formation of 24R, 25-dihydroxyvitamin D3. A. Mann, M.
L. Traba, and A. Rapado. Unidad Metabolica, Fundacion Jiménez
DIaz, Madrid, Spain. A possible production of 24R,25-dihydroxyvita-
mm D3 (24R,25(OH)2D3) outside the kidney has been investigated,
Wistar rats weighing 200 g fed on a normal diet (1.2% calcium, 0.7%
phosphate) were separated in two groups. One group of rats were
bilaterally nephrectomized (BNX3) and the other group sham-operated
(SO). Two microcuries of H-25-hydroxivitamin D3 (19.2 Ci/mmole)
were administered i.v. to both experimental groups. The animals were
bled 16, 24, 36, and 48 hr after operation through the suprahepatic vein.
Another two groups of rats were submitted to the same procedure
except that the 3H-25-hydroxivitamin D3 was not administered in this
case. All of these animals were bled 48 hr after operation. The vitamin
D3 metabolites were extracted with acetonitrile, purified through Sep-
pak Cl8 (Waters), and separated by high performance liquid chroma-
tography on normal phase (Waters system). A peak appeared which
coeluted with the standard 24R,25(OH)2D3 in both groups. The percent-
age of the total radioactivity injected which emerged with this peak at
the time was: 5.0 2.3%, 16 hr; 4.5 1.5%, 24 hr; 12.0 4.5%, 36 hr;
8.9 4.8%,48 hr, for the SO group and 1.7 0.7%, 16 hr; 0.9 0.3%,
24 hr; 4.7 2.4%, 36 hr; 1.5 0.4%, 47 hr for the BNX group. We did
not find any significant difference on the 24R,25(OH)2D3 levels between
both groups 48 hr after operation (2.2 0.9ng/ml, SO; 2.6 1.2 ng/ml,
BNX, P > 0.2). We conclude that the existence in the rat of extrarenal
production of 24R,25(OH)2D3 is maximal at 36 hr after kidneys are
removed. The normal levels of 24R,25(OH)2D3 in serum of BNX rats 48
hr after operation could be accounted for by a higher average life for
this metabolite in serum. Nevertheless, the possibility that the extrar-
enal 24R-hydroxilase supports the normal levels of 24R,25(OH)2D3 in
serum during this period cannot be eliminated.
